Low incidence but poor prognosis of complicated coeliac disease: A retrospective multicentre study

Digestive and Liver Disease

Volumn 46, Issue 3, 2014, Pages 227-230

  Biagi, Federico ^a   Gobbi, Paolo ^a   Marchese, Alessandra ^a   Borsotti, Edoardo ^a   Zingone, Fabiana ^b   Ciacci, Carolina ^b   Volta, Umberto ^c   Caio, Giacomo ^c   Carroccio, Antonio ^d   Ambrosiano, Giuseppe ^d   Mansueto, Pasquale ^d   Corazza, Gino R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

Author keywords

Celiac disease epidemiology; Gluten; Incidence; Prognosis; Risk assessment

Indexed keywords

ABDOMINAL B CELL LYMPHOMA; ABDOMINAL CANCER; ADULT; ARTICLE; B CELL LYMPHOMA; CASE CONTROL STUDY; CELIAC DISEASE; CONTROLLED STUDY; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; FEMALE; HUMAN; ILEITIS; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY CELIAC DISEASE TYPE 1; REFRACTORY CELIAC DISEASE TYPE 2; RETROSPECTIVE STUDY; SMALL INTESTINE CARCINOMA; ULCERATIVE JEJUNOILEITIS;

CELIAC DISEASE/EPIDEMIOLOGY; GLUTEN; INCIDENCE; PROGNOSIS; RISK ASSESSMENT;

ABDOMINAL NEOPLASMS; ADULT; AGED; CARCINOMA; CASE-CONTROL STUDIES; CELIAC DISEASE; COHORT STUDIES; ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA; FEMALE; HUMANS; INCIDENCE; INTESTINAL NEOPLASMS; INTESTINE, SMALL; ITALY; KAPLAN-MEIER ESTIMATE; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84893784324     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.10.010     Document Type: Article

References (26)

1. Biagi F., Klersy C., Balduzzi D., et al. Are we not over-estimating the prevalence of coeliac disease in the general population. Annals of Medicine 2010, 42:557-561.
2. Biagi F., Corazza G.R. Mortality in celiac disease. Nature Reviews Gastroenterology and Hepatology 2010, 15:8-16. 2.
3. Biagi F., Lorenzini P., Corazza G.R. Literature review on the clinical relationship between ulcerative jejunoileitis, coeliac disease, and enteropathy-associated T-cell. Scandinavian Journal of Gastroenterology 2000, 35:785-790.
4. Leslie L.A., Lebwohl B., Neugut A.I., et al. Incidence of lymphoproliferative disorders in patients with celiac disease. American Journal of Hematology 2012, 87:754-759.
5. Elfström P., Granath F., Ye W., Ludvigsson J.F. Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease. Clinical Gastroenterology and Hepatology 2012, 10:30-36.
6. Grainge M.J., West J., Card T.R., Holmes G.K. Causes of death in people with celiac disease spanning the pre- and post-serology era: a population-based cohort study from Derby, UK. American Journal of Gastroenterology 2011 May, 106:933-939.
7. Rampertab S.D., Forde K.A., Green P.H. Small bowel neoplasia in coeliac disease. Gut 2003, 52:1211-1214.
8. Roshan B., Leffler D.A., Jamma S., et al. The incidence and clinical spectrum of refractory celiac disease in a north American referral center. American Journal of Gastroenterology 2011, 106:923-928.
9. Malamut G., Afchain P., Verkarre V., et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009, 136:81-90.
10. Al-Toma A., Verbeek W.H., Hadithi M., et al. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 2007, 56:1373-1378.
11. Daum S., Ipczynski R., Schumann M., et al. High rates of complications and substantial mortality in both types of refractory sprue. European Journal of Gastroenterology and Hepatology 2009, 21:66-70.
12. Rubio-Tapia A., Kelly D.G., Lahr B.D., et al. Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 2009, 136:99-107.
13. Gale J., Simmonds P.D., Mead G.M., et al. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. Journal of Clinical Oncology 2000, 18:795-803.
14. Cellier C., Delabesse E., Helmer C., et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000, 356:203-208.
15. Biagi F., Corazza G.R. Defining gluten refractory enteropathy. European Journal of Gastroenterology and Hepatology 2001, 13:561-565.
16. Malamut G., Cellier C. Is refractory celiac disease more severe in old Europe. American Journal of Gastroenterology 2011, 106:929-932.
17. West J. Celiac disease and its complications: a time traveller's perspective. Gastroenterology 2009, 136:32-34.
18. Leffler D.A., Dennis M., Hyett B., et al. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clinical Gastroenterology and Hepatology 2007, 5:445-450.
19. Armitage P., Berry G. Statistical methods in medical research 1988, 205-213. Blackwell Scientific Publication, Oxford (GB). 2nd ed.
20. Kaplan E.L., Meier P. Non parametric estimation from incomplete observations. Journal of the American Statistical Association 1958, 53:457-481.
21. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer 1977, 35:1-39.
22. Cox D.R. Regression models and life tables. Journal of the Royal Statistical Society: Series B 1972, 34:187-220.
23. Corrao G., Corazza G.R., Bagnardi V., et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001, 358:356-361.
24. Murray J.A., Moore S.B., Van Dyke C.T., et al. HLA DQ gene dosage and risk and severity of celiac disease. Clinical Gastroenterology and Hepatology 2007, 5:1406-1412.
25. Al-Toma A., Goerres M.S., Meijer J.W., et al. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy associated T-cell lymphoma. Clinical Gastroenterology and Hepatology 2006, 4:315-319.
26. Biagi F., Bianchi P.I., Vattiato C., et al. The influence of HLA-DQ2 and DQ8 on severity in celiac disease. Journal of Clinical Gastroenterology 2012, 46:46-50.